//=time() ?>
Delighted to hear @BenjaminBesseMD discussing IO therapy options. PDL1 is king- TMB no role. Identifying pts that benefit: role for tumour burden, conmeds eg steroids, Neut/lymph ratio. HyperPD seems prevented by chemo-IO. Perhaps role for bev if liver Mets. #btog20